Skip to content

Journal Club

Quarterly Review of Publications by the GEST Research Committee


Join GEST’s Research Committee as we review current publications and breakthrough research that can impact IR’s practice and patient outcomes. The Journal Club will meet virtually online once per quarter. 

Topics and dates are listed below. 

EPOCH (Evaluating TheraSphere in Patients with metastatic colorectal carcinoma Of the liver who have progressed on first-line Chemotherapy) is the first study to investigate the role of transarterial radioembolization with Yttrium-90 (TARE) when added to standard-of-care second-line chemotherapy for colorectal liver metastases.

Join the Journal Club on March 19th to listen to Dr Riad SALEM ‘s presentation of the study and its results on delayed disease progression, and, with our experts panel, follow the discussion of subset analyses to better identify the ideal patients who could benefit most, as well as dosimetric considerations to optimize the risk-benefit profile of TARE exposure.

Physician Faculty: 

  • Dr. Shamar Young, University of Arizona
  • Dr. Beau Toskich, Mayo Clinic
  • Dr. Mohammad Khreiss, University of Arizona
  • Dr. Riad Salem, Feinberg School of Medicine
  • Dr. Sudhir Manda, Arizona Oncology

On-demand Button

Educational Grant provided by Boston Scientific


Dr. Shamar Young

University of Arizona

Dr. Beau Toskich

Dr. Beau Toskich

Mayo Clinic

Mohammad Khreiss

Dr. Mohammad Khreiss

University of Arizona

Dr Riad Salem

Dr. Riad Salem

Feinberg School of Medicine | Northwestern

Sudhir Manda

Dr. Sudhir Manda

Arizona Oncology


GEST Education

The GEST Group has developed premiere events including the annual GEST conference, focused topic meetings and summits where physicians come to learn from other physicians in the field of embolization.

Thank you to the following sponsor for supporting this educational event. ​

Boston Sientific